**The clinical part of the AngioSafe 1 T2D study includes an observational study, where exposure to, i.e., any GLP-1R agonist was assessed, and an interventional study, where the exposure to GLP-1R agonists only included liraglutide
Soft lithography in biology and microbiology
Marko M, Pawliczak R
For me, these GLP-1s seemed like a lifeline
4-5 for evidence-based instruction with real-world examples First-ever transcarotid artery revascularization trial with no strokes or device-related deaths Consensus statement outlines the team, infrastructure and experience needed to deliver TTVI safely and effectively Innovative approach to living-tissue AVR achieves low reintervention rates, excellent long-term survival Diagnosis and treatment of malnutrition and cachexia are key to improving cardiac outcomes Symptom burden at presentation is a potent predictor of long-term survival, large analysis shows
This variability means that users of compounded semaglutide or tirzepatide may experience slightly different effects at the "same" dose compared to brand-name users